Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Worswick who wrote (1087)	2/21/1998 9:00:00 AM
From: LPasko	Read Replies (1) \| Respond to of 2068

Worswick, you're right on the mark; these investors are no dummies. There are many reasons, I suppose, why institutional investors like these take a big stake in a company, rather than buy it out entirely, and all I could offer at this point would be speculation. In any event, $600 million is not chump change, and a turnaround is obviously foreseeable and indeed expected by some of the brightest financial minds of our time. Weren't almost all the analysts issuing strong buy signals when OXHP was over $70 a share? Now they are pessimistic, when Price, Bass, KKR, etc. are optimistic? Don't know why we waste so much breath on these "market savants."